Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
43,666,020
-
Total 13F shares
-
10,072,640
-
Share change
-
+10,072,640
-
Total reported value
-
$136,328,208
-
Price per share
-
$13.67
-
Number of holders
-
30
-
Value change
-
+$136,328,156
-
Number of buys
-
30
Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) as of Q3 2023
As of 30 Sep 2023,
Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,072,640 shares.
The largest 10 holders included
FMR LLC, Fairmount Funds Management LLC, 5AM Venture Management, LLC, Avidity Partners Management LP, VR Adviser, LLC, TANG CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, Nantahala Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, and Alphabet Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.